Management experiences of hematopoietic stem cell transplantation center under the pandemic of COVID-19
10.3760/cma.j.cn421203-20200502-00142
- VernacularTitle:COVID-19疫情下造血干细胞移植中心的管理经验
- Author:
Yi XIAO
1
;
Jinhuan XU
;
Yicheng ZHANG
;
Donghua ZHANG
;
Yang CAO
;
Ying WAN
;
Xi MING
;
Jianfeng ZHOU
Author Information
1. 华中科技大学同济医学院附属同济医院血液科，430030
- From:
Chinese Journal of Organ Transplantation
2020;41(5):281-285
- CountryChina
- Language:Chinese
-
Abstract:
With a global pandemic trend, coronavirus disease-2019 (COVID-19), starting a breakout in December 2019, has posed a great threat to people's lives, health and safety. Regarding how to manage hematopoietic stem cell transplantation (HSCT) center, treat non-COVID-19 HSCT patients, follow up patients after HSCT and resume the orderly treatment of transplant patients, our transplantation center has accumulated a wealth of practical experience and formulated a series of standard processes. This article was intended to summarize the management experiences of HSCT center under the pandemic of COVID-19 epidemic, provide references for effectively managing HSCT center in future public health crises and treat noncommunicable disease transplant patients in a timely and effective manner.
